KZIA · Kazia Therapeutics Ltd · Documents
Market Cap
$122.53M
Shares
15.55M
Volume · Oct 20
168.24K
Avg daily vol (3M)
278.94K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2024-09-13 | — | |
| 6-K | — | 2024-07-10 | — | |
| 6-K | — | 2024-06-24 | — | |
| 6-K | — | 2024-05-23 | — | |
| 6-K | — | 2024-05-17 | — | |
| 6-K | — | 2024-05-01 | — | |
| 6-K | — | 2024-04-19 | — | |
| 6-K | — | 2024-03-27 | 2023-12-31 | |
| 6-K | — | 2024-03-26 | — | |
| 6-K | — | 2024-02-21 | — | |
| 6-K | — | 2024-01-18 | — | |
| 6-K | — | 2024-01-12 | — | |
| 6-K | — | 2023-12-06 | — | |
| 6-K | — | 2023-12-01 | — | |
| 6-K | — | 2023-11-29 | — | |
| 6-K | — | 2023-11-29 | — | |
| 6-K | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-20 | — | |
| 6-K | — | 2023-11-15 | — | |
| 6-K | — | 2023-11-14 | — | |
| 6-K | — | 2023-11-01 | — | |
| 20-F | — | 2023-10-26 | 2023-06-30 | |
| 6-K | — | 2023-10-23 | — | |
| 6-K | — | 2023-10-13 | — | |
| 6-K | — | 2023-10-11 | — | |
| 6-K | — | 2023-10-10 | — | |
| 6-K | — | 2023-10-06 | — | |
| 6-K | — | 2023-09-29 | — | |
| 6-K | — | 2023-09-05 | — | |
| 6-K | — | 2023-08-11 | — | |
| 6-K | — | 2023-07-06 | — | |
| 6-K | — | 2023-06-26 | — | |
| 6-K | — | 2023-06-05 | — | |
| 6-K | — | 2023-05-01 | — | |
| 6-K | — | 2023-04-14 | — | |
| 6-K | — | 2023-04-04 | — | |
| 6-K/A | — | 2023-03-09 | 2022-12-31 | |
| 6-K | — | 2023-03-07 | — | |
| 6-K | — | 2023-02-28 | — | |
| 6-K | — | 2023-02-24 | — | |
| 6-K | — | 2023-02-24 | — | |
| 6-K | — | 2023-01-20 | — | |
| 6-K | — | 2023-01-17 | — | |
| 6-K | — | 2022-12-15 | — | |
| 6-K | — | 2022-12-12 | — | |
| 6-K | — | 2022-12-01 | — | |
| 6-K | — | 2022-11-16 | — | |
| 6-K | — | 2022-11-16 | — | |
| 6-K | — | 2022-11-03 | — | |
| 6-K | — | 2022-10-27 | — |
Showing 51–100 of 172 filings